OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
November 01, 2014
European CDMOs want into the US market, but entry options are limited.
October 02, 2014
The trend of exits from the CMO industry looks to be gaining momentum.
September 29, 2014
Multidirectional collaboration is critical for the new pharma business model; cloud-based information services can offer a communications alternative.
September 03, 2014
John S. Ross, executive vice president at Metrics Contract Services, provided commentary on the evolving role of contract services in solid/semi-solid dosage development and manufacturing.
Experts at Catalent Pharma Solutions provided commentary on the evolving role of contract services in analytical services, biologics drug development and manufacturing, and solid/semi-solid dosage development and manufacturing.
Experts from PPD provided commentary on the evolving role of contract services in analytical services.
Franco Negron, vice president of North America operations and integration at Patheon Inc., provided commentary on the evolving role of contract services in solid/semi-solid dosage development and manufacturing.
Mark Rogers, senior vice president at SGS Life Science Services, provided commentary on the evolving role of contract services in analytical services.
Experts at Dr. Reddy's CPS provided commentary on the evolving role of contract services in biologics drug development and manufacturing, and solid/semi-solid development manufacturing.
Peter Soelkner, general manager at Vetter Pharma International GmbH, provided commentary on the evolving role of contract services in parenteral drug development and manufacturing.